Curcusone D improves metabolic dysfunction associated steatotic liver disease via activation of the AMPK signaling
Molecular and Cellular Endocrinology · 2026-10 · 620 · 112847
DOI: 10.1016/j.mce.2026.112847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026-10. Verfasst von Danhua Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. Hauptthemen laut MEDLINE: Signal Transduction, AMP-Activated Protein Kinases, Fatty Liver, Sesquiterpenes. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Provincial Science and Technology Support Program, School of Medicine, Shanghai Jiao Tong University.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide with limited effective clinical treatments. Previous high-throughput drug screening identified Curcusone D as a promising candidate for MASLD treatment. This study aimed to validate its therapeutic effects and underlying molecular mechanism. In vivo efficacy was evaluated in high-fat and high-cholesterol (HFHC) diet-fed mice, while in vitro hepatocyte models were used for mechanistic verification. The results demonstrated that Curcusone D significantly improved liver function, reduced serum pro-inflammatory cytokines, and suppressed hepatic inflammation and fibrosis in MASLD mice. It also markedly reversed excessive lipid accumulation and inhibited inflammatory responses in hepatocytes. Mechanistically, Curcusone D specifically activated the adenosine monophosphate-activated protein kinase (AMPK) signaling pathway. Pharmacological inhibition of AMPK fully abolished the protective effects of Curcusone D against HFHC-induced hepatic steatosis, insulin resistance, inflammation and fibrosis. In conclusion, Curcusone D ameliorates MASLD progression via AMPK pathway activation, serving as a novel and druggable natural candidate for future MASLD clinical therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
- School of Laboratory Medicine/Clinical IVD Joint Research Center of Chengdu Medical College-Maccura Biotechnology, Chengdu Medical College, Chengdu, 610500, China.
- School of Clinical Medicine, Chengdu Medical College, Chengdu, 610500, China.
- Fatty Liver Disease Center of Integrated Chinese and Western Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210600, China.
- School of Laboratory Medicine/Clinical IVD Joint Research Center of Chengdu Medical College-Maccura Biotechnology, Chengdu Medical College, Chengdu, 610500, China. Electronic address: qiumin0227@163.com.
- Department of General Surgery, The Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. Electronic address: huangyuhua_1991@126.com.
Förderung
- National Natural Science Foundation of China
- Sichuan Provincial Science and Technology Support Program
- School of Medicine, Shanghai Jiao Tong University
- Chengdu Municipal Science and Technology Program
Zitieren
APA
Yao, D., Wen, S., Li, Q., Jia, Y., Wan, L., Qiu, M., Huang, Y., & Zhao, W. (2026). Curcusone D improves metabolic dysfunction associated steatotic liver disease via activation of the AMPK signaling. Molecular and Cellular Endocrinology, 620, 112847. https://doi.org/10.1016/j.mce.2026.112847
Vancouver
Yao D, Wen S, Li Q, Jia Y, Wan L, Qiu M, et al. Curcusone D improves metabolic dysfunction associated steatotic liver disease via activation of the AMPK signaling. Molecular and Cellular Endocrinology. 2026;620:112847. doi:10.1016/j.mce.2026.112847
BibTeX
@article{Yao2026,
author = {Yao, Danhua and Wen, Shengke and Li, Qi and Jia, Yiming and Wan, Lingfeng and Qiu, Min and Huang, Yuhua and Zhao, Wei},
title = {Curcusone D improves metabolic dysfunction associated steatotic liver disease via activation of the AMPK signaling},
journal = {Molecular and Cellular Endocrinology},
year = {2026},
volume = {620},
pages = {112847},
doi = {10.1016/j.mce.2026.112847}
}
EUVIMED